Results for tag: "Combination Antibody Therapy"

Combination Antibody Therapy is a type of oncology drug that combines two or more monoclonal antibodies to target cancer cells. This type of therapy is used to treat a variety of cancers, including breast, lung, and colorectal cancer. It works by blocking the growth of cancer cells and preventing them from spreading. The combination of antibodies can also help to reduce the side effects of chemotherapy and radiation therapy. Combination Antibody Therapy is becoming increasingly popular as a treatment for cancer due to its effectiveness and safety. It is also being used in combination with other treatments, such as immunotherapy, to improve outcomes. Some companies in the Combination Antibody Therapy market include Bristol-Myers Squibb, Merck, Roche, AstraZeneca, and Novartis. Show Less Read more